Pharmacokinetics of reboxetine, a new selective noradrenaline uptake inhibitor, in patients with various degrees of hepatic and renal insufficiency

Pharmacological Research

Volumn 35, Issue 3, 1997, Pages 239-

  Fiorentini, F ^a   Poggesi, I ^a   Jannuzzo, M G ^a   Duchene, P ^a   Strolin Benedetti, M ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CREATININE; REBOXETINE;

AREA UNDER THE CURVE; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CREATININE CLEARANCE; DISEASE SEVERITY; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; DRUG URINE LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KIDNEY FAILURE; LIVER FAILURE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; ULTRAVIOLET SPECTROSCOPY;

EID: 0030906294     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (0)